GATT: A Micro-invasive Glaucoma Surgery and a Big Step for Glaucoma Treatment

Authors

Mose Im, BS, Thomas Jefferson UniversityFollow

Abstract

Glaucoma is a group of ocular diseases characterized by damage to the optic nerve that may lead to permanent vision loss. Currently, 76 million people (aged 40-80 years) suffer from glaucoma, and the prevalence is projected to increase to 111.8 million by 2040.¹ The diagnosis of glaucoma can be frightening, particularly because there is no known cure. Fortunately, recent advancements in glaucoma surgery have made more options available for patients presenting with new-onset glaucoma. In particular, patients with mild to moderate glaucoma may be eligible for newer minimally invasive glaucoma surgeries (MIGS). This review is both an overview of MIGS, a new class of glaucoma surgeries, and a case study on how one of these novel procedures saved a 47-year-old woman’s vision.

Recommended Citation

Im, BS, Mose (2022) "GATT: A Micro-invasive Glaucoma Surgery and a Big Step for Glaucoma Treatment," inSIGHT: Vol. 2: Iss. 1, Article 6.
Available at: https://jdc.jefferson.edu/insight/vol2/iss1/6